Company Quick10K Filing
Pacific Gold & Royalty
Closing Price ($) Shares Out (MM) Market Cap ($MM)
$0.00 0 $0
10-Q 2018-03-31 Quarter: 2018-03-31
10-K 2017-12-31 Annual: 2017-12-31
10-K 2015-12-31 Annual: 2015-12-31
10-Q 2015-09-30 Quarter: 2015-09-30
10-Q 2015-06-30 Quarter: 2015-06-30
10-Q 2015-03-31 Quarter: 2015-03-31
10-K 2014-12-31 Annual: 2014-12-31
10-Q 2014-09-30 Quarter: 2014-09-30
10-Q 2014-06-30 Quarter: 2014-06-30
10-Q 2014-03-31 Quarter: 2014-03-31
10-K 2013-12-31 Annual: 2013-12-31
8-K 2018-03-12 Accountant

Pacific Gold & Royalty Financials

-

PCFG Metrics, Comps, Filings


Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Stockholders' Equity

Income Statement ($MM Quarter)

Revenue, Gross Profit, Net Income

Cash Flow ($MM Quarter)

Operating, Investing, Financing

Comps ($'000 TTM) Market Cap Assets Liabilities Revenue Gross Profit Net Income EBITDA EV
Apollo Education (APOL) 1,063,295 1,955,243 886,324 2,000,328 0 -19,719 98,213 579,272
China Crawfish (CACA) 2 0 0 0 -4 -4 -3
Mirenco (MREO)
Weyland Tech (WEYL) 10,602 5,280 29,462 -958 -4,242 -4,099 -5,303
Lingo Media (LMDC) 1,302 743 0 0 0 0 -0
Granite Real Estate (GRP)
Wewin Group (WWIN) 26 114 5 20 -95 -95 -20
MWF Global (MWF) 0 0 -34 -34 -1
Frontier Digital Media Group (FDMG) 5 31 32 0 -29 -29 -3
Brighthouse Life Insurance Co of Ny (BHNY) 9,065,749 8,029,864 236,819 0 0 2,514 -190,199
G-Mes Holdings (GMES) 1,262 812 652 609 67 141 -31
Baynon (BNON) 11 145 0 0 -21 -20 99
Immune Therapeutics (IMUN) 0 24 12,553 0 34 -5,080 -5,079 -21
Green Planet Bio Engineering (GPLB) 3,001 0 272 0 0 -38 -38 3,001
Blue Sphere (BLSP) 894 43,956 86,868 7,950 2,700 -14,453 -14,295 8,802
Therapeutic Solutions (TSOI) 0 367 1,851 13 10 -1,579 -1,236 481
Stem Holdings (STEMH) 40,803 5,703 958 364 -8,070 -7,496 -5,454
SpringWorks (SWTX)
Clean Coal Technologies (CCTC) 27 16,749 0 0 -5,795 -3,052 894
Ryanair Holdings (RYAA) 13,250,700 8,035,800 0 0 0 0 -34,900

Balance Sheet ($'000)2011-12-312012-03-312012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-09-302015-12-312017-12-312018-03-31
Cash10348912201062312170521000590
Accounts Receivable191813000
Inventory289249450
PP&E1,1991,1581,2531,2251,1881,15299588387086688823219800
Assets1,8211,6481,6161,4541,4241,3932,0221,9261,6811,0911,09948240610045590
Accounts Payable6558459771,0611,108996859900906854909890878435482397397
Long-Term Debt
Liabilities4,7055,1655,12615,0634,6324,3024,0724,3364,0033,8073,8152,7002,9102,8133,1023,8203,799
Stockholders' Equity-2,884-3,517-3,510-13,609-3,208-2,909-2,050-2,410-2,322-2,716-2,716-2,218-2,504-2,713-3,761-3,799
Income Statement ($'000)2011-12-312012-03-312012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-09-302015-12-312017-12-312018-03-31
Revenue4782000000000000
Cost of Revenue87362393939272714272625300
Gross Profit-39-280-39-39-39-27-27-14-27-26-25-300
R&D
SG&A
Tax000000170000
Net Income-1,382-2,580-221-515789-516-291-696-362-855-348144-344-38
Cash Flow ($'000)2011-12-312012-03-312012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-09-302015-12-312017-12-312018-03-31
Cash Operating-341-118-184-284-38-188-338-59-96-74-25-97
Cash Investing-7-3-3268-253727-4212382546
Cash Financing2481281761236-38168524240-8